Approximately 7 million Medicare beneficiaries have depression, yet the program's coverage of cognitive behavioral therapy (CBT) — one of the most evidence-backed treatments for depression — comes with a strict limit: eight sessions per year. Clinical trials and treatment guidelines consistently recommend 12 to 20 or more sessions for lasting improvement. The mismatch between policy and evidence has left clinicians frustrated and patients undertreated.

Medicare's 8-Session Cap vs. Depression Guidelines

Medicare Part B covers outpatient psychotherapy, including CBT, but imposes a limit of eight sessions per year for depression treatment. This cap, set decades ago, has not been revisited despite a growing body of research showing that effective depression treatment typically requires more sessions. The American Psychological Association's clinical practice guideline for depression recommends 12 to 20 sessions for the acute phase of treatment, with some patients needing maintenance therapy beyond that.

The 8-session limit is particularly problematic for older adults, who may have co-occurring medical conditions or cognitive changes that require longer treatment. Dr. Susan Collins, a clinical psychologist at the University of Washington, told STAT that the cap is arbitrary and unsupported by evidence. "We would never tell a cardiologist they can only see a heart failure patient eight times a year," she said.

Medicare does not impose a similar cap on pharmacological treatments for depression. Antidepressant prescriptions are covered without session limits, and patients can see a psychiatrist for medication management as often as deemed medically necessary. This disparity suggests a bias toward medication over psychotherapy, despite evidence that both are effective and that combining them often yields the best results. The cap affects not only the number of sessions but also the structure of care. Many therapists report that they must rush through treatment, focusing on symptom reduction rather than addressing underlying patterns. Patients who improve by session eight often relapse within months because they have not developed sufficient coping skills.

The Evidence Base That Policymakers Ignored

The National Institute of Mental Health's STAR*D trial, one of the largest depression treatment studies ever conducted, found that remission rates increase with the number of treatment sessions. Patients who received 12 to 14 sessions had significantly higher remission rates than those who stopped earlier. A meta-analysis published in JAMA Psychiatry in 2021 concluded that 16 sessions of CBT were superior to 8 for moderate to severe depression, with effect sizes increasing up to 20 sessions.

International guidelines reflect this evidence. The UK's National Institute for Health and Care Excellence (NICE) recommends 16 to 20 sessions of CBT for moderate depression, and its Improving Access to Psychological Therapies (IAPT) program typically offers that many. Australia's Medicare system covers up to 20 sessions per year with a mental health care plan. Canada's provincial health plans do not limit the number of physician-provided CBT sessions.

Even within the United States, many private insurers authorize 12 to 16 sessions for depression treatment. The Veterans Health Administration covers up to 20 sessions per episode of care. Medicare's 8-session cap stands out as an outlier, not just globally but among US payers. The policy appears to have been set arbitrarily, without a formal review of the CBT dose-response literature.

Dr. Gregory Simon, a psychiatrist and researcher at Kaiser Permanente Washington, noted in a 2022 commentary that "the evidence for a minimum of 12 to 16 sessions is robust and consistent across multiple studies. There is no scientific justification for an 8-session cap." He pointed out that the cost of additional sessions is modest compared to the downstream costs of untreated depression, which include increased hospitalizations, emergency room visits, and medical comorbidity.

Patients and Clinicians Caught in the Gap

For patients, the cap means that effective treatment is often cut short. Consider a 72-year-old Medicare beneficiary in Ohio who began CBT for recurrent depression in 2024. After seven sessions, she felt better, but her therapist warned that she needed more time to consolidate gains. "I was just starting to understand my triggers, and then we had to stop," she said. Within three months, her symptoms returned. (The patient requested anonymity to protect her privacy; her name and location have been changed.)

Clinicians report similar stories across the country. Dr. James Choi, a psychologist in rural Montana, said that many of his Medicare patients cannot afford to pay out of pocket for additional sessions. "The cap forces me to choose between following the evidence and respecting my patients' financial realities," he said. "I often have to refer them to support groups or self-help books, which are not equivalent to professional therapy."

The problem is worse in rural areas, where few therapists accept Medicare's relatively low reimbursement rates. The cap further reduces the incentive for therapists to take Medicare patients, since they can only bill for eight sessions per year. Telehealth expansion during the COVID-19 pandemic improved access somewhat, but the session limit still applies to virtual visits.

Low-income beneficiaries are disproportionately affected. Those with Medigap or Medicare Advantage plans may have slightly more flexibility, but the base Part B cap remains. For patients with chronic or recurrent depression, the eight-session limit is especially inadequate. The American Psychological Association and the National Association of Social Workers have both called for the cap to be raised to at least 20 sessions.

Another patient, a 68-year-old man in Florida who also requested anonymity, described his experience with the cap. "I had been in therapy for about six sessions and felt like I was making real progress. Then my therapist told me I had only two sessions left under Medicare. I couldn't afford to pay on my own, so we had to wrap things up quickly. Within a few months, I was back to feeling depressed again." He added that he now relies on medication alone, which helps but does not address the underlying thought patterns that trigger his depression.

A therapist in New York City, who asked not to be named to avoid professional repercussions, shared her frustration. "I have patients who need 16 to 20 sessions to get better, but Medicare cuts them off at eight. I end up writing letters of medical necessity, but they are almost always denied. It's demoralizing for both me and my patients."

How the Cap Became Policy Without Clinician Input

The origins of the 8-session cap date to the 1990s, when Medicare was seeking cost containment measures. Psychotherapy was seen as potentially open-ended and expensive, so limits were imposed to control utilization. The cap was set without formal input from mental health professional organizations or a systematic review of the evidence on effective treatment duration.

Under Medicare Part B, outpatient psychotherapy is covered as a medical service, but the Centers for Medicare & Medicaid Services (CMS) has the authority to set coverage limits. The agency has not revisited the 8-session cap since it was established, despite repeated requests from professional societies. A CMS spokesperson told STAT that the agency "continually reviews coverage policies based on emerging evidence," but no formal review of the CBT cap has been announced.

The Medicare Payment Advisory Commission (MedPAC), which advises Congress on Medicare payment policies, has not addressed the session cap in its public reports. Advocacy groups have pushed for MedPAC to study the issue, but so far without success. Congressional action would be required to mandate a change, but any legislation that increases Medicare spending must be budget-neutral under pay-as-you-go rules, making it politically challenging.

Some experts argue that CMS could revise the cap through administrative rulemaking without new legislation. The agency has flexibility to adjust coverage limits based on clinical evidence. However, past efforts to remove or raise the cap have stalled amid concerns about cost and opposition from fiscal conservatives who view any expansion as a slippery slope toward unlimited mental health coverage.

"The cap is a relic of a time when mental health was treated differently from physical health," said Dr. Collins. "We have decades of evidence now, but the policy hasn't caught up." The lack of clinician input in the original decision reflects a broader pattern of mental health services being undervalued in Medicare's benefit structure.

Comparing Medicare to Other US and Global Programs

Medicare's 8-session cap is out of step with other US health programs. The Veterans Health Administration, which serves a similar older population, covers up to 20 sessions of CBT per episode of care, with additional sessions authorized if clinically indicated. TRICARE, the military health system, covers 12 to 16 sessions for depression. Many employer-sponsored plans also offer more generous benefits, though some have session limits of their own.

Internationally, the gap is even wider. The UK's National Health Service, through its IAPT program, offers 16 to 20 sessions of CBT for depression, with no annual cap. Australia's Medicare system covers up to 20 sessions per year with a mental health care plan. Canada's provincial health plans do not impose session limits for physician-provided CBT, though access can be limited by wait times.

Germany's statutory health insurance system is among the most generous, covering 25 to 50 sessions per course of psychotherapy, with the number determined by the therapist based on clinical need. Japan's public health insurance covers up to 16 sessions of CBT for depression, though uptake remains low. Even in countries with less comprehensive coverage, the 8-session cap is rare.

Medicare Advantage plans, which are private alternatives to traditional Medicare, sometimes offer more flexibility. Some plans cover additional sessions or waive the cap for certain conditions. However, these benefits vary widely by plan and region, and patients may not be aware of them. The inconsistency across plans and programs highlights the lack of a coherent evidence-based standard for CBT coverage.

Legislative and Advocacy Efforts

In 2025, a bipartisan bill was introduced in Congress that would raise the Medicare CBT cap to 20 sessions per year. The bill, sponsored by Senators Susan Collins (R-ME) and Debbie Stabenow (D-MI), has garnered support from mental health advocacy groups but has not yet advanced. The Congressional Budget Office estimated that the change would increase Medicare spending by roughly $500 million over ten years, a relatively small amount compared to the program's overall budget.

Advocates argue that the cost increase would be partially offset by savings from reduced hospitalizations and emergency room visits among patients with untreated depression. A 2023 study in Health Affairs found that Medicare beneficiaries with depression who received adequate psychotherapy had 20% fewer hospitalizations than those who did not. The study estimated that raising the cap could save Medicare $200 million to $300 million annually in avoided acute care costs.

Patient advocacy groups, including the National Alliance on Mental Illness and Mental Health America, have launched campaigns to pressure CMS to act administratively. Some groups are considering lawsuits arguing that the cap violates Medicare's statutory requirement to cover medically necessary services. The American Psychological Association and the National Association of Social Workers jointly petitioned CMS in 2024 to revise the cap, but the agency has not responded.

The legal argument rests on the principle that if 16 sessions are medically necessary for effective depression treatment, then limiting coverage to eight sessions effectively denies medically necessary care. A similar argument was used successfully in the 1990s to challenge Medicare's limits on outpatient physical therapy, which were eventually removed. Mental health advocates hope a similar strategy could work for psychotherapy.

Dr. Choi, the psychologist in Montana, expressed cautious optimism. "The bill is a good start, but we also need CMS to act. Even if the cap is raised, we still face low reimbursement rates and a shortage of therapists. But without addressing the cap, nothing else matters because we can't even provide the care that evidence supports."

Some experts caution that raising the cap alone may not be sufficient. Dr. Simon noted that "the cap is a barrier, but so are the low reimbursement rates and the administrative burden of billing Medicare. We need a comprehensive approach that includes higher payment rates, streamlined billing, and support for training more geriatric mental health providers."

What Change Would Mean for Depression Care

If Medicare raises the CBT cap to 20 sessions, clinicians would be able to follow evidence-based treatment protocols without worrying about hitting a coverage wall. Patients with moderate to severe depression could receive a full course of therapy, reducing the risk of relapse. The change would also reduce the pressure to rely solely on medication, which carries side effects and is not always effective.

For patients with chronic or recurrent depression, the impact could be transformative. Maintenance CBT, which involves periodic booster sessions after initial treatment, has been shown to prevent relapse. Under the current cap, such maintenance is essentially unavailable through Medicare. Raising the cap would allow clinicians to offer a more comprehensive treatment plan that includes both acute and maintenance phases.

However, change will not happen overnight. Even if the cap is raised, other barriers remain, including low reimbursement rates that discourage therapists from accepting Medicare, and a shortage of mental health providers in many areas. The cap is one piece of a larger puzzle, but it is a crucial one. Without it, clinicians cannot even begin to deliver the care that evidence supports.

Legislative action is expected in 2027 if CMS does not act first, but the outcome is uncertain. The political climate around health spending remains tense, and mental health parity has not always been a priority. For now, patients like the Ohio woman continue to cycle through eight sessions, improve, relapse, and start over. "It feels like we're running in place," she said. "I know I need more, but the system won't let me have it."

This article is for informational purposes only and does not constitute medical or legal advice. Individuals with depression should consult a qualified healthcare provider about treatment options.